Tarsus Pharmaceuticals, Inc. - 8-K Filing
Tarsus Pharmaceuticals completed $270M acquisition of Alkeus Pharmaceuticals, including up-front cash and stock consideration with potential milestone payments totaling $350M. (Items: 2.01 Completion of Acquisition or Disposition of Assets, 8.01 Other Events, 9.01 Financial Statements and Exhibits)
Tickers: $TARS